Lifestyle Changes and Glycemic Control in T1D

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-29

Study Completion Date

2020-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pakistani studies report non-adherence to self-management by type 1 diabetes (T1D) patients, and episodes of hypoglycemia and ketoacidosis as acute complications. Self-management guidelines include maintenance of logbooks for blood glucose, physical activity, and dietary intake, that affect glycated hemoglobin (HbA1C) and acute complications. The proposed study will evaluate whether mobile messaging for maintaining log books for blood glucose or e-device use for step count will modify HbA1c levels to be examined at three and six months after enrollment. In addition, episodes of acute complications and blood glucose variability will be correlated with daily log book maintenance and step counts.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

IMPACT OF DIABETES HEALTHCARE PROGRAM ON GLYCEMIC CONTROL AND SELF-EFFICACY AMONG TYPE-II DIABETICS IN ISLAMABAD PAKISTAN

NCT06719076

HbA1c

COMPLETED NA

Promoting Self-management Behaviors in Adolescents With Type 1 Diabetes, Using Digital Storytelling

NCT04608058

Diabetes Mellitus, Type 1 Self-Management

COMPLETED NA

Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients

NCT07144696

Type 1 Diabetes Mellitus

RECRUITING NA

HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)

NCT03598400

Type1diabetes

COMPLETED NA

Type 1 Diabetes Virtual Self-management Education and Support

NCT05756829

type1diabetes

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Type 1 diabetes (T1D) occurs due to destruction of insulin producing beta cells in pancreas. T1D usually occurs in children and young individuals, and requires continuous blood glucose monitoring for adjustment of insulin dosage on a daily basis. Incidence of T1D has been increasing over the past three decades. Hyperglycemia and ketoacidosis episodes are common adverse effects due to irregular monitoring of daily blood glucose. It is a big challenge in developed as well as developing countries to live with T1D due to less optimal use of timely entry in logbook for self-monitoring of blood glucose (SMBG). Current guidelines recommend SMBG use in all patients with diabetes. According to a study, increased daily frequency of SMBG was significantly associated with lower glycated hemoglobin (HbA1C) along with added benefits of fewer acute complications among children and adolescents. Available literature from Pakistan highlights non-adherence of T1D patients to recommended dietary advice (58.5%), physical activity (42.3%) and prescribed insulin regimen (88.1%). Use of mobile applications has been shown to increase the medication adherence and use of self-blood glucose testing. Increased daily step count by T1D patients helped to reduce the risk of cardiovascular events. A wearable e-device accompanied with an application (Fitbit App) tracks step count by recording data in mobile application. HbA1C levels acts as an indicator for the glycemic control and correlates with complications. However, HbA1C cannot determine the daily variability of blood glucose, thus SMBG can help predict the average daily risk reduction in T1D complications. The proposed study will address the adherence to standard protocols for maintaining home based records by patients and caregivers and insulin therapy, optimizing the quarterly HbA1C levels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type1 Diabetes Mellitus Life Style Behavioral Changes Self-Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

A factorial design approach will be taken to study the lifestyle change for self-management of T1D. A randomized controlled method will enroll patients in four groups. All groups will be working with a standard log book for documenting blood sugar and routine care as advise by doctors, nurses, and nutritionists. First group will be entirely of routine care follow up, second group will receive additional e-device for step count (fitbit), third group will receive routine care and e-messages as reminders to maintain a daily log book, and fourth group will be receiving e-device for step count (fitbit) and e-messages for maintain blood glucose and step count log book in addition to routine care. All four groups will be followed up for a period of six months. Log book data will be obtained at a monthly interval and HbA1c as a main outcome will be measured three times, at baseline, at three and six months.

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine Care

This group will be followed up for routine care, maintaining a standard log book for documenting blood sugar and insulin dosages per advice and explanation by doctors, nurses and nutritionists.

Group Type NO_INTERVENTION

No interventions assigned to this group

e-device for step count (fit-bit)

This group will receive e-device for step count (fit-bit) in addition to routine care.

Group Type ACTIVE_COMPARATOR

e-device for step count (fit-bit)

Intervention Type DEVICE

Patients in this group will receive fitbit device to count their daily steps and record it into their log books.

e-messages for log book

This group will receive daily e-messages for maintaining log book in addition to routine care.

Group Type ACTIVE_COMPARATOR

e-messages for log book

Intervention Type BEHAVIORAL

Patients in this group will receive e-messages to maintain their log books as per instruction for blood sugar levels and send back weekly through snap shot.

e-messages for log book & fit-bit

This group will receive e-device for step count (fit-bit), daily e-messages for maintaining log book for blood sugar, insulin dosages and step count in addition to routine care.

Group Type ACTIVE_COMPARATOR

e-device for step count (fit-bit)

Intervention Type DEVICE

Patients in this group will receive fitbit device to count their daily steps and record it into their log books.

e-messages for log book & fit-bit

Intervention Type BEHAVIORAL

Patient in this group will receive e-messages to maintain their log books for blood sugar levels as well as use fitbit device and maintain their log book for daily step count and send back weekly through snap shot.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

e-device for step count (fit-bit)

Patients in this group will receive fitbit device to count their daily steps and record it into their log books.

Intervention Type DEVICE

e-messages for log book

Patients in this group will receive e-messages to maintain their log books as per instruction for blood sugar levels and send back weekly through snap shot.

Intervention Type BEHAVIORAL

e-messages for log book & fit-bit

Patient in this group will receive e-messages to maintain their log books for blood sugar levels as well as use fitbit device and maintain their log book for daily step count and send back weekly through snap shot.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient diagnosed with T1D \> 6 months
* Patient's age ≥ 15 years
* Patient or any one of the family member like father, mother or sibling using smart phone.
* Patient or any one of the family member know how to use (receive calls or read text message) a smart phone.

Exclusion Criteria

* Patient on insulin pump
* Pregnant females,
* Patient with neurodevelopmental delay or thalassemia
* Patient currently using any kind of authentic e-device for step count or physical activity.

Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes